plerixafor has been researched along with Diffuse Large B-Cell Lymphoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alcoceba, M; Blanco, O; Bosch, R; Casanova, I; Céspedes, MV; Dieguez-Gonzalez, R; Gallardo, A; Gonzalez-Díaz, M; Grañena, A; Mangues, R; Moreno, MJ; Mozos, A; Novelli, S; Pavón, MÁ; Sierra, J | 1 |
Mahmud, N; Nimmagadda, S; Park, Y; Rondelli, D; Sweiss, K | 1 |
Aabideen, K; Anoop, P; Ethell, ME; Potter, MN | 1 |
3 other study(ies) available for plerixafor and Diffuse Large B-Cell Lymphoma
Article | Year |
---|---|
CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.
Topics: Animals; Benzylamines; Cell Line, Tumor; Cell Movement; Cyclams; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; In Vitro Techniques; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Invasiveness; Prognosis; Receptors, CXCR4; Survival Rate; Xenograft Model Antitumor Assays | 2015 |
Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF.
Topics: Anti-HIV Agents; Benzylamines; Cyclams; Cyclosporine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Leukapheresis; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2010 |
The feasibility of plerixafor as a second-line stem cell mobilizing agent in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Child; Child, Preschool; Cyclams; Drug-Related Side Effects and Adverse Reactions; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Medulloblastoma; Neoplasm Staging; Wilms Tumor | 2011 |